| Assessment Status | Rapid Review Complete |
| HTA ID | 23003 |
| Drug | Voclosporin |
| Brand | Lupkynis® |
| Indication | Voclosporin is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class III, IV or V (including mixed class III/V and IV/V) lupus nephritis (LN). |
| Assessment Process | |
| Rapid review commissioned | 10/01/2023 |
| Rapid review completed | 10/02/2023 |
| Rapid review outcome | A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of voclosporin compared with the current standard of care. |
